FGFR blockade inhibits targeted therapy-tolerant persister cells in basal FGFR1 and FGF2 high expressing cancers with driver oncogenes
Preprint in Research Square (January 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Combination of the natural product mensacarcin with vemurafenib (Zelboraf) combats BRAF mutant and chemo-resistant melanoma in vitro by affecting cell metabolism and cellular migration
Article in Advances in Cancer Biology - Metastasis (December 2022)
Dipotassium Glycyrrhizinate on Melanoma Cell Line: Inhibition of Cerebral Metastases Formation by Targeting NF-kB Genes-Mediating MicroRNA-4443 and MicroRNA-3620—Dipotassium Glycyrrhizinate Effect on Melanoma †
Article in International Journal of Molecular Sciences (June 2022)